文献库，生知库 | 链接生命科学的每一步

Matsumoto, Hisako; Kanemitsu, Yoshihiro; Ohe, Motoki; Tanaka, Hiroshi; Terada, Kunihiko; Nishi, Koichi; Atsuta, Ryo; Hara, Johsuke; Saito, Junpei; Ohmichi, Mitsuhide; Ishizuka, Tamotsu; Nishiuma, Teruaki; Inoue, Hideki; Watanabe, Naoto; Nagano, Tatsuya; Ueda, Tetsuya; Ogawa, Haruhiko; Endo, Shigeru; Suzuki, Takeshi; Kita, Toshiyuki; Fujimori, Katsuya; Ishiura, Yoshihisa; Fujimura, Masaki; Niimi, Akio

发表日期：2025

文献求助收藏

Anesthetic Management Using Remimazolam for Dental Treatment in a Pediatric Patient With Dravet Syndrome

使用瑞马唑仑进行麻醉管理，用于患有Dravet综合征的儿科患者的牙科治疗

期刊:Anesthesia Progress

影响因子:

doi:10.2344/24-0045

Sawada, Musashi; Honma, Shoichi; Iida, Akira; Atsuta, Ryo; Ishida, Yoshiyuki; Fukushima, Kazuaki

发表日期：2025

文献求助收藏

Elevated mepolizumab levels in patients with severe asthma responsive to 1 year's mepolizumab treatment

接受一年美泊利单抗治疗后病情得到缓解的重度哮喘患者体内美泊利单抗水平升高

期刊:Journal of Allergy and Clinical Immunology Global

影响因子:

doi:10.1016/j.jacig.2025.100410

Nishimaki, Takayasu; Sasano, Hitoshi; Harada, Sonoko; Takeshige, Tomohito; Sandhu, Yuuki; Tanabe, Yuki; Matsuno, Kei; Nagaoka, Tetsutaro; Ito, Jun; Atsuta, Ryo; Ohuchi, Mayu; Yagishita, Shigehiro; Hamada, Akinobu; Takahashi, Kazuhisa; Harada, Norihiro

哮喘

发表日期：2025

文献求助收藏

Japanese Patients with Severe Asthma Identified as Responders to Omalizumab Treatment at 2 Years Based on the GETE Score Continued Treatment for an Extended Period

根据 GETE 评分，日本重度哮喘患者在接受奥马珠单抗治疗 2 年后被认定为有效，并继续接受长期治疗。

期刊:Journal of Asthma and Allergy

影响因子:3

doi:10.2147/JAA.S423256

Goto, Ai; Harada, Sonoko; Sasano, Hitoshi; Sandhu, Yuuki; Tanabe, Yuki; Abe, Sumiko; Ueda, Shoko; Takeshige, Tomohito; Matsuno, Kei; Nagaoka, Tetsutaro; Ito, Jun; Atsuta, Ryo; Takahashi, Kazuhisa; Harada, Norihiro

哮喘

发表日期：2024

文献求助收藏

Differences between oscillometry measurements obtained by MostGraph-01 and MasterScreen-IOS in patients with asthma

MostGraph-01 和 MasterScreen-IOS 两种示波法测量方法在哮喘患者中的差异

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0309981

Harada, Sonoko; Harada, Norihiro; Sasano, Hitoshi; Tanabe, Yuki; Kotajima, Masaki; Sato, Yoshihiko; Takeshige, Tomohito; Katsura, Yoko; Ito, Jun; Atsuta, Ryo; Kurosawa, Hajime; Takahashi, Kazuhisa

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen

日本柳杉花粉舌下免疫疗法对日本柳杉花粉引起的季节性过敏性鼻炎哮喘患者的影响

期刊:Biomolecules

影响因子:4.8

doi:10.3390/biom12040518

Ueda, Shoko; Ito, Jun; Harada, Norihiro; Harada, Sonoko; Sasano, Hitoshi; Sandhu, Yuuki; Tanabe, Yuki; Abe, Sumiko; Shiota, Satomi; Kodama, Yuzo; Nagaoka, Tetsutaro; Makino, Fumihiko; Chiba, Asako; Akiba, Hisaya; Atsuta, Ryo; Miyake, Sachiko; Takahashi, Kazuhisa

Enhanced airway hyperresponsiveness in asthmatic children and mice with A(H1N1)pdm09 infection

哮喘儿童和感染A(H1N1)pdm09病毒的小鼠气道高反应性增强

期刊:Immunity Inflammation and Disease

影响因子:2.7

doi:10.1002/iid3.406

Ariyoshi, Taira; Tezuka, Junichiro; Yasudo, Hiroki; Sakata, Yasufumi; Nakamura, Tamaki; Matsushige, Takeshi; Hasegawa, Hideki; Nakajima, Noriko; Ainai, Akira; Oga, Atsunori; Itoh, Hiroshi; Shirabe, Komei; Toda, Shoichi; Atsuta, Ryo; Ohga, Shouichi; Hasegawa, Shunji

Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma

美泊利单抗降低了哮喘患者血清中半乳糖凝集素-10和嗜酸性粒细胞阳离子蛋白的水平

期刊:Asia Pacific Allergy

影响因子:2.1

doi:10.5415/apallergy.2021.11.e31

Kobayashi, Konomi; Nagase, Hiroyuki; Sugimoto, Naoya; Yamamoto, Shiho; Tanaka, Akihiko; Fukunaga, Koichi; Atsuta, Ryo; Tagaya, Etsuko; Hojo, Masayuki; Gon, Yasuhiro

Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database

接受每日一次氟替卡松糠酸酯/维兰特罗或每日两次氟替卡松丙酸酯/沙美特罗作为维持治疗的哮喘患者：基于索赔数据库的分析

期刊:Pulmonary Therapy

影响因子:3

doi:10.1007/s41030-018-0084-4

Atsuta, Ryo; Takai, Jun; Mukai, Isao; Kobayashi, Akihiro; Ishii, Takeo; Svedsater, Henrik

哮喘

发表日期：2018

文献求助收藏

Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E

腱生蛋白-C作为哮喘新型生物标志物的特性：腱生蛋白-C与骨膜蛋白或免疫球蛋白E联合应用的临床价值

期刊:Allergy Asthma and Clinical Immunology

影响因子:2.4

doi:10.1186/s13223-018-0300-7

Yasuda, Mina; Harada, Norihiro; Harada, Sonoko; Ishimori, Ayako; Katsura, Yoko; Itoigawa, Yukinari; Matsuno, Kei; Makino, Fumihiko; Ito, Jun; Ono, Junya; Tobino, Kazunori; Akiba, Hisaya; Atsuta, Ryo; Izuhara, Kenji; Takahashi, Kazuhisa

Real-world usage and response to gefapixant in refractory chronic cough

格法匹坦在难治性慢性咳嗽中的真实世界应用及疗效

Anesthetic Management Using Remimazolam for Dental Treatment in a Pediatric Patient With Dravet Syndrome

使用瑞马唑仑进行麻醉管理，用于患有Dravet综合征的儿科患者的牙科治疗

Elevated mepolizumab levels in patients with severe asthma responsive to 1 year's mepolizumab treatment

接受一年美泊利单抗治疗后病情得到缓解的重度哮喘患者体内美泊利单抗水平升高

Japanese Patients with Severe Asthma Identified as Responders to Omalizumab Treatment at 2 Years Based on the GETE Score Continued Treatment for an Extended Period

根据 GETE 评分，日本重度哮喘患者在接受奥马珠单抗治疗 2 年后被认定为有效，并继续接受长期治疗。

Differences between oscillometry measurements obtained by MostGraph-01 and MasterScreen-IOS in patients with asthma

MostGraph-01 和 MasterScreen-IOS 两种示波法测量方法在哮喘患者中的差异

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen

日本柳杉花粉舌下免疫疗法对日本柳杉花粉引起的季节性过敏性鼻炎哮喘患者的影响

Enhanced airway hyperresponsiveness in asthmatic children and mice with A(H1N1)pdm09 infection

哮喘儿童和感染A(H1N1)pdm09病毒的小鼠气道高反应性增强

Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma

美泊利单抗降低了哮喘患者血清中半乳糖凝集素-10和嗜酸性粒细胞阳离子蛋白的水平

Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database

接受每日一次氟替卡松糠酸酯/维兰特罗或每日两次氟替卡松丙酸酯/沙美特罗作为维持治疗的哮喘患者：基于索赔数据库的分析

Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E

腱生蛋白-C作为哮喘新型生物标志物的特性：腱生蛋白-C与骨膜蛋白或免疫球蛋白E联合应用的临床价值